UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Arylalkylamine vanadium salts as new anti-diabetic compounds

Journal of inorganic biochemistry, 2009-04, Vol.103 (4), p.559-566

2009

Volltextzugriff (PDF)

New Efficient Substrates for Semicarbazide-Sensitive Amine Oxidase/VAP-1 Enzyme: Analysis by SARs and Computational Docking

Journal of medicinal chemistry, 2006-10, Vol.49 (21), p.6197-6208

2006

Volltextzugriff (PDF)

Oral Insulin-Mimetic Compounds That Act Independently of Insulin

Diabetes (New York, N.Y.), 2007-02, Vol.56 (2), p.486-493

2007

Volltextzugriff (PDF)

Exploring the Binding Mode of Semicarbazide-Sensitive Amine Oxidase/VAP-1: Identification of Novel Substrates with Insulin-like Activity

Journal of medicinal chemistry, 2004-09, Vol.47 (20), p.4865-4874

2004

Volltextzugriff (PDF)

Understanding the Mechanism of Action of the Novel SSAO Substrate (C7NH10)6(V10O28)·2H2O, a Prodrug of Peroxovanadate Insulin Mimetics

Chemical biology & drug design, 2007-06, Vol.69 (6), p.423-428

2007

Volltextzugriff (PDF)

Insulin-mimetic compound hexaquis (benzylammonium) decavanadate is antilipolytic in human fat cells

World journal of diabetes, 2017-04, Vol.8 (4), p.143-153

2017

Volltextzugriff (PDF)

Understanding the Mechanism of Action of the Novel SSAO Substrate (C sub(7)NH sub(10)) sub(6)(V sub(10)O sub(28</ sub>)).2H sub(2)O, a Prodrug of Peroxovanadate Insulin Mimetics

Chemical biology & drug design, 2007-06, Vol.69 (6), p.423-428

2007

Volltextzugriff (PDF)

Understanding the Mechanism of Action of the Novel SSAO Substrate (C 7 NH 10 ) 6 (V 10 O 28 )·2H 2 O, a Prodrug of Peroxovanadate Insulin Mimetics

Chemical biology & drug design, 2007-06, Vol.69 (6), p.423-428

2007

Volltextzugriff (PDF)

Regulation of BDNF release by ARMS/Kidins220 through modulation of Synaptotagmin-IV levels

The Journal of neuroscience, 2018-06, Vol.38 (23), p.5415-5428

2018

Volltextzugriff (PDF)

Regulatory landscape fusion in rhabdomyosarcoma through interactions between the PAX3 promoter and FOXO1 regulatory elements

Genome Biology, 2017-06, Vol.18 (1), p.106-106, Article 106

2017

Volltextzugriff (PDF)

Monitoring CD49d Receptor Occupancy: A Method to Optimize and Personalize Natalizumab Therapy in Multiple Sclerosis Patients

Cytometry. Part B, Clinical cytometry, 2018-03, Vol.94 (2), p.327-333

2018

Volltextzugriff (PDF)

Evaluation of Kappa Index as a Tool in the Diagnosis of Multiple Sclerosis: Implementation in Routine Screening Procedure

Frontiers in neurology, 2021-08, Vol.12, p.676527-676527

2021

Volltextzugriff (PDF)

Enhanced TrkA signaling impairs basal forebrain-dependent behavior

Frontiers in molecular neuroscience, 2023-09, Vol.16, p.1266983-1266983

2023

Volltextzugriff (PDF)

Association between knowledge and attitudes towards advance directives in emergency services

BMC medical ethics, 2021-06, Vol.22 (1), p.1-75, Article 75

2021

Volltextzugriff (PDF)

Results from a national survey on the management of primary hyperparathyroidism

Journal of endocrinological investigation, 2012-12, Vol.35 (11), p.957-963

2012

Volltextzugriff (PDF)

Managing ethical aspects of advance directives in emergency care services

Nursing ethics, 2021-02, Vol.28 (1), p.91-105

2021

Volltextzugriff (PDF)

Arg913Gln variation of SLC12A3 gene is associated with diabetic nephropathy in type 2 diabetes and Gitelman syndrome: a systematic review

BMC nephrology, 2019-10, Vol.20 (1), p.393-393, Article 393

2019

Volltextzugriff (PDF)

Progressive multifocal leukoencephalopathy associated to natalizumab extended dosing regimen

Neurodegenerative disease management, 2015-10, Vol.5 (5), p.399-402

2015

Volltextzugriff (PDF)

Stopping Disease Modifying Therapy in Multiple Sclerosis Patients (P3.113)

Neurology, 2016-04, Vol.86 (16_supplement)

2016

Volltextzugriff (PDF)

Conocimiento y Valoración de las Voluntades Anticipadas del Personal Sanitario de Unidades de Hospitalización a Domicilio, Oncología Médica, Hospitales de Día y Servicios de Urgencias

Medicina paliativa, 2019, Vol.26

2019

Volltextzugriff (PDF)

Implantation of a biochemical and genetic screening programme for family hypercholesterolaemia. Collaboration between the clinical laboratory and lipid units: Design of the ARIAN Project

Clinica e investigacion en arteriosclerosis : publicacion oficial de la Sociedad Espanola de Arteriosclerosis, 2021-11, Vol.33 (6), p.289

2021

Volltextzugriff (PDF)

Implantación de un programa de cribado bioquímico y genético de hipercolesterolemia familiar. Colaboración entre el laboratorio clínico y las unidades de lípidos: diseño del Proyecto ARIAN

Clínica e investigación en arteriosclerosis, 2021-11, Vol.33 (6), p.289-295

2021

Volltextzugriff (PDF)

Relationship between clinical manifestation of MS relapse and Gadolinium enhancing lesions in brain MRI (P3.375)

Neurology, 2018-04, Vol.90 (15_supplement)

2018

Volltextzugriff (PDF)

A multicentre, randomized, double-blind, non-inferiority clinical trial to compare the clinical and radiological efficacy of 625 mg versus 1250 mg of oral methylprednisolone in patients with relapse of multiple sclerosis: Oral-CORTEM trial. (S31.008)

Neurology, 2017-04, Vol.88 (16_supplement)

2017

Volltextzugriff (PDF)

A study of the differences in the request of glycated hemoglobin in primary care in Spain: A global, significant, and potentially dangerous under-request

Clinical biochemistry, 2014-08, Vol.47 (12), p.1104-1107

2014

Volltextzugriff (PDF)

1 – 25 von 30

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(26)
Mit Volltextzugriff
(23)

Publikationsform

Artikel
(29)
Buchkapitel
(1)

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Arylalkylamine vanadium salts as new anti-diabetic compounds

New Efficient Substrates for Semicarbazide-Sensitive Amine Oxidase/VAP-1 Enzyme: Analysis by SARs and Computational Docking

Oral Insulin-Mimetic Compounds That Act Independently of Insulin

Exploring the Binding Mode of Semicarbazide-Sensitive Amine Oxidase/VAP-1: Identification of Novel Substrates with Insulin-like Activity

Understanding the Mechanism of Action of the Novel SSAO Substrate (C7NH10)6(V10O28)·2H2O, a Prodrug of Peroxovanadate Insulin Mimetics

Insulin-mimetic compound hexaquis (benzylammonium) decavanadate is antilipolytic in human fat cells

Understanding the Mechanism of Action of the Novel SSAO Substrate (C sub(7)NH sub(10)) sub(6)(V sub(10)O sub(28</ sub>)).2H sub(2)O, a Prodrug of Peroxovanadate Insulin Mimetics

Understanding the Mechanism of Action of the Novel SSAO Substrate (C 7 NH 10 ) 6 (V 10 O 28 )·2H 2 O, a Prodrug of Peroxovanadate Insulin Mimetics

Regulation of BDNF release by ARMS/Kidins220 through modulation of Synaptotagmin-IV levels

Regulatory landscape fusion in rhabdomyosarcoma through interactions between the PAX3 promoter and FOXO1 regulatory elements

Monitoring CD49d Receptor Occupancy: A Method to Optimize and Personalize Natalizumab Therapy in Multiple Sclerosis Patients

Evaluation of Kappa Index as a Tool in the Diagnosis of Multiple Sclerosis: Implementation in Routine Screening Procedure

Enhanced TrkA signaling impairs basal forebrain-dependent behavior

Association between knowledge and attitudes towards advance directives in emergency services

Results from a national survey on the management of primary hyperparathyroidism

Managing ethical aspects of advance directives in emergency care services

Arg913Gln variation of SLC12A3 gene is associated with diabetic nephropathy in type 2 diabetes and Gitelman syndrome: a systematic review

Progressive multifocal leukoencephalopathy associated to natalizumab extended dosing regimen

Stopping Disease Modifying Therapy in Multiple Sclerosis Patients (P3.113)

Conocimiento y Valoración de las Voluntades Anticipadas del Personal Sanitario de Unidades de Hospitalización a Domicilio, Oncología Médica, Hospitales de Día y Servicios de Urgencias

Implantation of a biochemical and genetic screening programme for family hypercholesterolaemia. Collaboration between the clinical laboratory and lipid units: Design of the ARIAN Project

Implantación de un programa de cribado bioquímico y genético de hipercolesterolemia familiar. Colaboración entre el laboratorio clínico y las unidades de lípidos: diseño del Proyecto ARIAN

Relationship between clinical manifestation of MS relapse and Gadolinium enhancing lesions in brain MRI (P3.375)

A multicentre, randomized, double-blind, non-inferiority clinical trial to compare the clinical and radiological efficacy of 625 mg versus 1250 mg of oral methylprednisolone in patients with relapse of multiple sclerosis: Oral-CORTEM trial. (S31.008)

A study of the differences in the request of glycated hemoglobin in primary care in Spain: A global, significant, and potentially dangerous under-request

Suchergebnisse filtern